Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON22544
NL-OMON22544
Not yet recruiting
Not Applicable

ational observational study to monitor the new guideline concerning treatment of atypical hemolytic uremic syndrome

Radboud university medical center0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsatypische hemolytisch uremisch syndroom, atypical hemolytic uremic syndrome, complement system, eculizumab, restrictive treatment regimen, orphan drugs, weesgeneesmiddel

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
atypische hemolytisch uremisch syndroom, atypical hemolytic uremic syndrome, complement system, eculizumab, restrictive treatment regimen, orphan drugs, weesgeneesmiddel
Sponsor
Radboud university medical center
Enrollment
50
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients of all ages, suspected of or diagnosed with aHUS
  • •2\. Treated conform the new Dutch guideline for aHUS.

Exclusion Criteria

  • •1, Subject and/or his parents is not able or willing to sign the Informed Consent before start of the study.
  • •2\. Patients with other etiological forms of HUS than aHUS

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
ational observational study to monitor the new guideline concerning treatment of atypical hemolytic uremic syndromeacute kidney failurecomplement mediated hemolytic uremic syndrome1002142910029149
NL-OMON44007Radboud Universitair Medisch Centrum50
Completed
Not Applicable
Observational study monitoring the effects of oral cabergoline on avoidance of symptoms of Ovarian Hyperstimulation Syndrome (OHSS) in patients at risk of ovarian hyperstimulation syndrome when undergoing an In-Vitro Fertilisation (IVF) cycleOvarian hyperstimulation syndrome (OHSS)Reproductive Health and Childbirth - Fertility including in vitro fertilisation
ACTRN12609000222246Fertility Specialists of Western Australia100
Completed
Not Applicable
Validatie onderzoek activiteiten monitor New Wellness Solutionsgeen aaandoeningenEnergy expenditurephysical activity
NL-OMON31285niversiteit Maastricht36
Recruiting
Not Applicable
An observational study investigating and auditing the safety, tolerability and further efficacy characteristics of a pharmaceutical grade cannabis medicine (NanaBis™) prescribed to eligible patients for the management of cancer related or non-cancer related pain in general and specialty medical practices.Cancer related painnon-cancer related painCancer - Any cancerAnaesthesiology - Pain management
ACTRN12619000513112Medlab Clinical2,000
Not yet recruiting
Not Applicable
Observational Study to understand the Changes in The Body Composition and Skin Parameters in after Udvartana.
CTRI/2024/01/061227Dr Athira S NAir